Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine

Akromegali

Yazarlar: Bekir UÇAN, Taner DEMİRCİ

Cilt 2 , Sayı 2 , 2019 , Sayfalar 62 - 67

Konular:Sağlık Bilimleri ve Hizmetleri

DOI:10.32322/jhsm.485584

Anahtar Kelimeler:Acromegaly,Diagnosis,Treatment

Özet: Acromegaly is the clinical syndrome that results from excessive secretion of growth hormone (GH). The most common cause of acromegaly is a GH secreting adenoma of the anterior pituitary. The onset of acromegaly is insidious, and its progression is usually very slow. Nearly all patients with acromegaly have acral osseous and soft tissue overgrowth. The characteristic findings are an enlarged jaw and enlarged, swollen hands and feet. Patients with acromegaly appear to be at increased risk for cadiovascular disase, colon cancer, thyroid cancer and other tumors. Death is generally caused by cardiovascular diseases. Transsphenoidal surgery is the main therapy for patients with an acromegaly. After surgical failure long-acting somatostatin analog, cabergolin or pegvisomant are indicated. If adenoma size increases or GH/IGF-1 hypersecretion persists despite medical therapy, we suggest radiation therapy (RT) or repeat surgery. 


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2019, title={Akromegali}, volume={2}, number={2}, publisher={Journal of Health Sciences and Medicine}, author={Bekir UÇAN,Taner DEMİRCİ}, year={2019}, pages={62–67} }
APA
KOPYALA
Bekir UÇAN,Taner DEMİRCİ. (2019). Akromegali (Vol. 2, pp. 62–67). Vol. 2, pp. 62–67. Journal of Health Sciences and Medicine.
MLA
KOPYALA
Bekir UÇAN,Taner DEMİRCİ. Akromegali. no. 2, Journal of Health Sciences and Medicine, 2019, pp. 62–67.